Interventional Radiology Market

Interventional radiology is a branch of medicine which deals with a variety of therapeutic and diagnostic procedures that are performed using minimally invasive image-guided techniques to diagnose & treat a variety of diseases. Interventional radiology (IR) can be used in the field of angioplasty, stenting, image-guided thermal ablation, embolization, thrombolysis, biopsies, and more. It can be used to cure and/or alleviate symptoms of vascular disease, cancer, stroke, uterine fibroids, and more. These procedures have less risk, less pain, and less recovery time in comparison to open surgery. Moreover, compared to the conventional surgery, interventional radiology offers less blood loss and a lower risk for infection and other common complications that come with open surgery.

Market Dynamics:

High prevalence of chronic disease, rise in number of minimally invasive surgeries, increasing geriatric population, and advancements in interventional radiology are major factors expected to propel the growth of the global interventional radiology market over the forecast period. The ageing population tends to have a higher prevalence of chronic diseases, and can have profound impact on the health and quality of life of elder population. For instance, the incidence of cancer increases dramatically with age, most likely due to a build-up of risks for specific cancers that increase with age. Thus, there has been an increase in the use of IR technologies. According to the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States.

Key features of the study:

• This report provides in-depth analysis of the global interventional radiology market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global interventional radiology market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Siemens Healthineers, Shimadzu Corporation, Samsung Medison (Samsung Electronics Co. Ltd), Hologic, Inc., Fujifilm Holdings Corporation, Carestream Health, Koninklijke Philips, Esaote SPA, and Canon Inc. (Canon Medical Systems Corporation), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global interventional radiology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional radiology market.

Detailed Segmentation:

• Global Interventional Radiology Market, By Product:
• • MRI Systems
  • Ultrasound Imaging Systems
  • CT Scanners
  • Angiography Systems
  • Fluoroscopy Systems
  • Biopsy Devices
  • Other Products
• Global Interventional Radiology Market, By Application:
• • Cardiology
  • Urology and Nephrology
  • Oncology
  • Gastroenterology
  • Other Applications
• Global Interventional Radiology Market, By Geography:
• • North America
  • Europe
  • Asia-Pacific
  • Middle East
  • Africa
  • South America